MAIA Biotechnology, Inc.
MAIA
$2.35
$0.0050.21%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.04M | 1.52M | 1.76M | 1.63M | 2.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.00M | 4.19M | 3.82M | 3.95M | 6.38M |
| Operating Income | -5.00M | -4.19M | -3.82M | -3.95M | -6.38M |
| Income Before Tax | -3.57M | -2.74M | -8.88M | -8.07M | -6.26M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.57M | -2.74M | -8.88M | -8.07M | -6.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.57M | -2.74M | -8.88M | -8.07M | -6.26M |
| EBIT | -5.00M | -4.19M | -3.82M | -3.95M | -6.38M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.14 | -0.11 | -0.40 | -0.46 | -0.40 |
| Normalized Basic EPS | -0.09 | -0.07 | -0.25 | -0.29 | -0.25 |
| EPS Diluted | -0.14 | -0.11 | -0.40 | -0.46 | -0.40 |
| Normalized Diluted EPS | -0.09 | -0.07 | -0.25 | -0.29 | -0.25 |
| Average Basic Shares Outstanding | 25.04M | 23.90M | 22.20M | 17.60M | 15.48M |
| Average Diluted Shares Outstanding | 25.04M | 23.90M | 22.20M | 17.60M | 15.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |